Article Details

Argent BioPharma Full Year 2024 Earnings: AU$0.47 loss per share (vs AU$7.07 loss in FY 2023)

Retrieved on: 2024-09-01 23:28:25

Tags for this article:

Click the tags to see associated articles and topics

Argent BioPharma Full Year 2024 Earnings: AU$0.47 loss per share (vs AU$7.07 loss in FY 2023). View article details on hiswai:

Excerpt

Argent BioPharma ( ASX:RGT ) Full Year 2024 Results Key Financial Results Revenue: AU$891.1k (down 74% from FY 2023...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo